Ascendis Pharma A/S Operating Income

Ascendis Pharma A/S (ASND) currently reports a operating income of $110M as of June 2026. That compares with $-250M in the prior-year period — up 143.2% year over year. Use the charts on this page to explore Ascendis Pharma A/S's operating income history and peer comparisons.

Ascendis Pharma A/S's operating income increased from $-250M to $110M — a 143.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ascendis Pharma A/S reported $110M in operating income as of June 2026. That compares with $-250M in the prior-year period — up 143.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ascendis Pharma A/S, and consider following ASND for alerts when major investors trade the stock.

Ascendis Pharma A/S is classified in the Healthcare sector. On operating income, it currently shows $110M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ASND with unrelated industries.